Merck & Co.
AWARDS
NEWS
The company announced today that it had positive results in a Phase III clinical trial evaluating the drug for insomnia in patients with mild-to-moderate Alzheimer’s disease dementia.
Biopharma has several unique challenges, but one of them is the patent cliff. In an industry where only about one in 10 compounds actually makes it to market on average, those drugs aren’t able to stay on the market very long before their patents end and generic competition begins.
For those select few who achieve the role of chief executive officer of a multi-national corporation, the compensation packages are typically quite large – especially when compared to the average salaries of company employees.
Merck & Co. filed with the U.S. Securities and Exchange Commission that it plans an extensive restructuring of its manufacturing and supply network. This will, it indicates, reduce its “global real estate footprint.”
NHS England will acquire hepatitis C drugs from the companies at competitive prices and work to identify patients around the country.
As the measles virus continues to run throughout the United States, Merck, the sole supplier of the MMR vaccine, said it has taken steps to increase the supply of the medication to medical facilities across the United States to help battle the outbreak.
JOBS
IN THE PRESS